IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
Risk or presence of metastasis in medulloblastoma causes substantial treatment-related morbidity and overall mortality. Through the comparison of cytokines and growth factors in the cerebrospinal fluid (CSF) of metastatic medulloblastoma patients with factors also in conditioned media of metastatic...
Main Authors: | Svalina, Matthew N., Kikuchi, Ken, Abraham, Jinu, Lal, Sangeet, Davare, Monika A., Settelmeyer, Teagan P., Young, Michael C., Peckham, Jennifer L., Cho, Yoon-Jae, Michalek, Joel E., Hernandez, Brian S., Berlow, Noah E., Jackson, Melanie, Guillaume, Daniel J., Selden, Nathan R., Bigner, Darell D., Nazemi, Kellie J., Green, Sarah C., Corless, Christopher L., Gultekin, Sakir, Mansoor, Atiya, Rubin, Brian P., Woltjer, Randall, Keller, Charles |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891740/ |
Similar Items
-
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma
by: Kikuchi, Ken, et al.
Published: (2013) -
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
by: Chandramohan, Vidyalakshmi, et al.
Published: (2013) -
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
by: Huang, Guo‐Hao, et al.
Published: (2016) -
Adult medulloblastoma
by: Rege S.V., et al.
Published: (2016-12-01) -
Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
by: Jenkins, Noah C, et al.
Published: (2014)